Data as of Apr 17
| +0.19 / +1.44%|
The 5 analysts offering 12-month price forecasts for Horizon Pharma Inc have a median target of 21.00, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a +57.07% increase from the last price of 13.37.
The current consensus among 5 polled investment analysts is to Buy stock in Horizon Pharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.